Revelation Capital Management, LLC Quant / Systematic

Name: Revelation Capital Management, LLC Q2 2022 13F Filing | 13F Explorer
Creator: Revelation Capital Management, LLC
Published: 2022-08-15

Location: Sausalito, CA

CIK: 0001801811 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $7.067M (100.0% shares, 0.0% debt)

Holdings (3)

— SINGULAR GENOMICS SYSTEMS INC 76.5%

Value $5.409M Shares 1,415,846 Share Price $3.82 Est. Cost/Share $11.56 Unrealized @ Report Date —

NPCE NEUROPACE INC 17.4%

Value $1.228M Shares 248,127 Share Price $4.95 Est. Cost/Share $12.99 Unrealized @ Report Date -61.9%

— ACCOLADE INC 6.1%

Value $430K Shares 58,050 Share Price $7.41 Est. Cost/Share $7.41 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	SINGULAR GENOMICS SYSTEMS INC	1,415,846	$5.409M	76.5%	$3.82	$11.56	—	COM	82933R100
NPCE	NEUROPACE INC	248,127	$1.228M	17.4%	$4.95	$12.99	-61.9%	COM	641288105
—	ACCOLADE INC	58,050	$430K	6.1%	$7.41	$7.41	—	COM	00437E102